Table 2. APS events during the five years of the follow-up.
N.S.: Non significant.
| Total | Group-1 N = 244 | Control N = 221 | P |
Odds ratio |
95% CI |
||||
|---|---|---|---|---|---|---|---|---|---|
| CONDITION | N | % | N | % | N | % | |||
| Total APS events |
45 | (9.7%) | 38 | (15.6%) | 7 | (3.2%) | <0.001 | 5.64 | 2.46 to 12.91 |
| Venous thrombosis | 18 | (3.9%) | 15 | (6.1%) | 3 | (1.4%) | 0.008 | 4.76 | 1.36 to 16.67 |
| Deep venous thrombosis | 12 | (2.6%) | 10 | (4.1%) | 2 | (0.9%) | 0.028 | 4.68 | 1.01 to 21.60 |
| Pulmonary embolism | 6 | (1.3%) | 5 | (2%) | 1 | (0.5%) | N.S. | — | — |
| Arterial thrombosis | 25 | (5.4%) | 21 | (8.6%) | 4 | (1.8%) | 0.001 | 5.11 | 1.73 to 15.13 |
| Peripheral arteries | 4 | (0.9%) | 3 | (1.2%) | 1 | (0.5%) | N.S. | — | — |
| Stroke | 13 | (2.8%) | 11 | (4.5%) | 2 | (0.9%) | 0.022 | 5.17 | 1.13 to 23.59 |
| Myocardial infarction | 8 | (1.7%) | 7 | (2.9%) | 1 | (0.5%) | 0.070 (N.S) | 6.5 | 0.79 to 53.24 |
| Gestational morbidity * | 2 | (0.4%) | 2 | (0.8%) | 0 | (0%) | N.S. | — | — |